News & Coverage
Ketamine One Advances Research Capabilities via Controlled Substance Dealers Licence Application
The Company and Its Subsidiary KGK Science Have Also Completed the Pre-Qualification Audits of Its Canadian Facilities to Enable Clinical Trials in an Arrangement with Aleafia Health July 28, 2021 ...
CFN Media
Jul 28, 2021
Entheon Biomedical Further Strengthens Advisory Board with Appointment of Dr. Andy Greenshaw
Vancouver, British Columbia–(Newsfile Corp. – July 28, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on devel...
CFN Media
Jul 28, 2021
AOC's Amendment To Allow Federal Research Into Benefits Of Psychedelics Rejected By House Again
The U.S. House of Representatives voted down an amendment Tuesday filed by Rep. Alexandria Ocasio-Cortez that sought to remove constraints to researching the therapeutic potential of psychedelic ...
YAHOO!Finance
Jul 28, 2021
Cybin Receives Final Approval to Commence Trading on the NYSE American on or About August 5
Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has received approval for the listing ...
아크로팬
Jul 28, 2021
Silo Pharma Awarded Notice of Allowance from United States Patent and Trademark Office for Homing Peptide Patent
Central Nervous System Homing Peptide under development to deliver Psychedelics including Psilocybin Englewood Cliffs NJ, July 27, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB:SILO), a developm...
CFN Media
Jul 27, 2021